Latest News about Marijuana
Recent news which mentions Marijuana
What's In The Cards For These Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season
October 28, 2022
From Benzinga
Why Is Weed So Good At Nausea Relief? And Does CBD Help, Too?
October 28, 2022
From Benzinga
From Benzinga
Key Cannabis Exec Changes You Need To Know About: Leafly's New CCO, Glass House's New Appointment & More
October 25, 2022
From Benzinga
Canopy Growth looks to speed up entry into U.S. cannabis market with new holding company
October 25, 2022
From CNBC.com News
Biden Says No Pardon For Weed Sellers, Delaware Wants Cannabis Legal, Court Rules Pot Equipment Can Be Imported
October 24, 2022
From Benzinga
Curaleaf Labeling Mix-Up Epilogue: Here's How The Cannabis Giant Is Quietly Settling Lawsuits
October 24, 2022
Tickers
CURLF
From Benzinga
Analysts Love These 5 Cannabis Stocks
October 20, 2022
From Benzinga
Another Marijuana Firm Dumps A NY Cannabis Deal: Analyst Reveals Future Acquisition Targets And Their M&A Outlook
October 17, 2022
From Benzinga
Meet The Longest Serving Non-Violent Cannabis Offender In Michigan's History, New Doc Streaming Soon
October 17, 2022
From Benzinga
South Carolina Gubernatorial Opponents Spar Over Cannabis Legalization, Gov. McMaster Vs. Joe Cunningham
October 14, 2022
From Benzinga
Humble & Fume Reports YoY Drop In Q4 Revenue, Expects Further Topline Growth In 2023
October 14, 2022
Tickers
HUMBF
From Benzinga
Here's What Needs To Happen Next For Marijuana Stocks To Be Uplisted On Major US Exchanges
October 13, 2022
Tickers
MSOS
From Benzinga
Here's What Investors Need To Know About Biden's Marijuana Pardons
October 12, 2022
From Benzinga
From Benzinga
From Benzinga
From CNBC.com News
This Canadian Retailer Is Positioned For US Market Entry, Plans To Launch Cannabis Sales In These States
October 11, 2022
Tickers
FFLWF
From Benzinga
From Benzinga
Cannabis Share Prices Surge On Biden's Pardon For Weed Possession, Analyst's Insight On This Stock
October 07, 2022
From Benzinga
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
October 07, 2022
From Benzinga
From Benzinga
From CNBC.com News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.